A J Venkatakrishnan

12PUBLICATIONS
16CO-AUTHORS
Disease surveillanceRespiratory diseasesDeep learningBehavioural epidemiologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 15, 2026
GLP-1-based incretin therapy is associated with lower incident Alzheimer's disease and cardiorenal events in adults with documented neuropsychiatric, cognitive, or sensory risk.

|Aug 01, 2026
Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection.

|Jul 11, 2026
Auditable large language model curation of clinical notes refines glucagon-like peptide-1 initiation, persistence ascertainment, and compounding use beyond prescription records.

|Jun 18, 2026
Weight-loss dynamics with tirzepatide versus semaglutide.

|May 21, 2026
Weight trajectories after last tirzepatide or semaglutide prescription across a federated health network.

|May 18, 2026
Decoding the hallmarks of GLP-1RA weight-loss super-responders.

Pageof 2

Frequent Collaborators

10 joint publications

Venky Soundararajan

3 joint publications

Praveen Anand

1 joint publications

Melis Kayikci

1 joint publications

James Scott-Brown